
July 2023 FDA Watch
Key approvals announced in June represented important steps forward for the lab testing industry.
Key approvals announced in June represented important steps forward for the lab testing industry.
The outlook of the global genetic testing market based on recent reports from five financial consulting firms.
After an eventful month in the Illumina-GRAIL saga, the story may soon be over.
Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.